Escalon Medical Corp (ESMC) stock
ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026Market cap $2.72MP/E 0.7Yield –
Escalon Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Escalon Medical's operating cash flow for the twelve months ending Jun 30, 2026 was -$402.60K, down 205.7% year over year. For fiscal 2026 it was -$402.60K, down 205.7% from the year before. The highest annual figure on record is $838.71K in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$402.60K | -205.7% |
| FY2025 | Jun 30, 2025 | $380.73K | – |
| FY2024 | Jun 30, 2024 | -$602.77K | -285.4% |
| FY2023 | Jun 30, 2023 | $325.15K | – |
| FY2022 | Jun 30, 2022 | -$1.05M | -225.2% |
| FY2021 | Jun 30, 2021 | $838.71K | – |
| FY2020 | Jun 30, 2020 | -$168.50K | – |
| FY2019 | Jun 30, 2019 | -$472.69K | -542.9% |
| FY2018 | Jun 30, 2018 | $106.74K | – |
| FY2017 | Jun 30, 2017 | -$506.00K | – |
| FY2016 | Jun 30, 2016 | -$1.02M | – |
| FY2015 | Jun 30, 2015 | -$456.53K | – |
| FY2014 | Jun 30, 2014 | -$622.61K | – |
| FY2013 | Jun 30, 2013 | -$1.93M | – |
| FY2012 | Jun 30, 2012 | -$700.57K | – |
| FY2011 | Jun 30, 2011 | -$514.94K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$251.18K | -1693.8% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $280.98K | +815.4% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$517.42K | -271.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $85.01K | +155.1% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $15.76K | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $30.70K | -82.5% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $300.94K | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $33.33K | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$339.87K | -195.8% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $175.19K | -27.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$322.13K | -909.7% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$115.96K | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $354.93K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $240.82K | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $39.79K | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$310.38K | – |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$452.80K | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$15.68K | -112.7% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$188.06K | -207.1% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -$393.39K | -172.7% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$1.08K | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $123.14K | -73.5% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $175.57K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $541.08K | +7450.6% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$497.85K | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $465.03K | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$142.84K | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $7.17K | -39.4% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$101.33K | -544.4% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$122.66K | -133.6% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$260.53K | – |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $11.83K | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $22.80K | -81.9% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $365.14K | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -$106.67K | – |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$174.53K | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $126.18K | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$115.34K | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -$351.25K | – |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -$165.58K | – |
See a number that looks wrong?